new_0222_0463|ARQT|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0463|ARQT|1|Arcutis Biotherapeutics Inc Total Current Assets (Quarterly) (USD)|Arcutis Biotherapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Arcutis Biotherapeutics Inc Inventories (Quarterly) (USD)|Arcutis Biotherapeutics Inc Net PP&E (Quarterly) (USD)|Arcutis Biotherapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Arcutis Biotherapeutics Inc Total Liabilities (Quarterly) (USD)|Arcutis Biotherapeutics Inc Total Current Liabilities (Quarterly) (USD)|Arcutis Biotherapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Arcutis Biotherapeutics Inc Total Deposits (Quarterly) (USD)|Arcutis Biotherapeutics Inc Book Value (Quarterly) (USD)|Arcutis Biotherapeutics Inc Retained Earnings (Quarterly) (USD)|Arcutis Biotherapeutics Inc Treasury Stock (Quarterly) (USD)|Arcutis Biotherapeutics Inc EV to Revenues|Arcutis Biotherapeutics Inc EV to Earnings|Arcutis Biotherapeutics Inc EV to Free Cash Flow|Arcutis Biotherapeutics Inc EV to Assets (Quarterly)|Arcutis Biotherapeutics Inc PS Ratio|Arcutis Biotherapeutics Inc PE Ratio|Arcutis Biotherapeutics Inc Price to Book Value|Arcutis Biotherapeutics Inc PEG Ratio|Arcutis Biotherapeutics Inc Debt to Equity Ratio|Arcutis Biotherapeutics Inc Dividend Yield|Arcutis Biotherapeutics Inc Shareholder Yield (TTM)|Arcutis Biotherapeutics Inc Percent of Shares Outstanding Short|Arcutis Biotherapeutics Inc Total Receivables (Quarterly) (USD)|Arcutis Biotherapeutics Inc Total Payables (Quarterly) (USD)|Arcutis Biotherapeutics Inc Total Capital Stock (Quarterly) (USD)|Arcutis Biotherapeutics Inc Return on Invested Capital|Arcutis Biotherapeutics Inc Quality Ratio Score|Arcutis Biotherapeutics Inc Momentum Score|Arcutis Biotherapeutics Inc Beta (1Y)|Arcutis Biotherapeutics Inc Sustainable Growth Rate (TTM)|Arcutis Biotherapeutics Inc Institutional Investor Ownership Percentage|Arcutis Biotherapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Arcutis Biotherapeutics Inc Total Employees (Annual)|Arcutis Biotherapeutics Inc EPS Diluted (Quarterly) (USD)|Arcutis Biotherapeutics Inc SG&A Expense (Quarterly) (USD)|Arcutis Biotherapeutics Inc Shares Outstanding|Arcutis Biotherapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Arcutis Biotherapeutics Inc Ordinary Shares Number (Quarterly)|Arcutis Biotherapeutics Inc Payout Ratio|Arcutis Biotherapeutics Inc Quick Ratio (Quarterly)|Arcutis Biotherapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Arcutis Biotherapeutics Inc Stock Buybacks (Quarterly) (USD)|Arcutis Biotherapeutics Inc Effective Tax Rate (TTM)|Arcutis Biotherapeutics Inc Return on Equity|Arcutis Biotherapeutics Inc Net Income (TTM) (USD)|Arcutis Biotherapeutics Inc Revenue (TTM) (USD)|Arcutis Biotherapeutics Inc Dividend Per Share (Quarterly) (USD)|Arcutis Biotherapeutics Inc Revenue (Quarterly) (USD)|Arcutis Biotherapeutics Inc Gross Profit (Quarterly) (USD)|Arcutis Biotherapeutics Inc Pre-Tax Income (Quarterly) (USD)|Arcutis Biotherapeutics Inc Net Income (Quarterly) (USD)|Arcutis Biotherapeutics Inc Net Interest Income (Quarterly) (USD)|Arcutis Biotherapeutics Inc Price (USD)|Arcutis Biotherapeutics Inc Total Return Price (USD)|Arcutis Biotherapeutics Inc Enterprise Value (USD)|Arcutis Biotherapeutics Inc 30-Day Average Daily Volume|Arcutis Biotherapeutics Inc 1 Year Price Returns (Daily)|Arcutis Biotherapeutics Inc Short Interest|Arcutis Biotherapeutics Inc PE Ratio (Forward)|Arcutis Biotherapeutics Inc PE Ratio (Forward 1y)|Arcutis Biotherapeutics Inc PS Ratio (Forward)|Arcutis Biotherapeutics Inc PS Ratio (Forward 1y)|Arcutis Biotherapeutics Inc Quarterly EPS Estimates (USD)|Arcutis Biotherapeutics Inc Quarterly Revenue Estimates (USD)|Arcutis Biotherapeutics Inc Quarterly EPS Surprise|Arcutis Biotherapeutics Inc Quarterly Revenue Surprise|Arcutis Biotherapeutics Inc Quarterly Actual EPS (USD)|Arcutis Biotherapeutics Inc Quarterly Actual Revenue (USD)|Arcutis Biotherapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Arcutis Biotherapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Arcutis Biotherapeutics Inc Price Target (USD)|Arcutis Biotherapeutics Inc Consensus Recommendation|Arcutis Biotherapeutics Inc Price Target Num Estimates|Arcutis Biotherapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Arcutis Biotherapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Arcutis Biotherapeutics Inc Research and Development Expense (Quarterly) (USD)|Arcutis Biotherapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Arcutis Biotherapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Arcutis Biotherapeutics Inc Land and Improvements (Quarterly) (USD)|Arcutis Biotherapeutics Inc Buildings and Improvements (Quarterly) (USD)|Arcutis Biotherapeutics Inc Other Properties (Quarterly) (USD)|Arcutis Biotherapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0463|ARQT|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0463|ARQT|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0463|ARQT|5|111.555555556|111.555555556||111.555555556||111.555555556|111.555555556|111.555555556||111.555555556|111.555555556||||1.44594594595||||1.44444444444|||1.44594594595||15.2291666667|91.2857142857|111.555555556|111.555555556|||34|30.4166666667|||91.2727272727|91.2857142857|91.2727272727|91.2727272727|30.8095238095||111.555555556|||91.2727272727|91.4|||91.375|||||91.2727272727|91.2727272727||1.44594594595|1.44594594595|1.44594594595|1.44580777096|1.43609022556|15.2291666667|||1.44117647059|1.44755244755|91.3333333333|91.3333333333|91.2857142857||91.2857142857|91.2857142857|23.1515151515|30.7826086957|22.53125|8.48235294118|22.53125|16.6086956522|20.2285714286|91.2727272727|91.2727272727||||91.375|111.555555556||
new_0222_0463|ARQT|6|9|9||9||9|9|9||9|9||||518||||477|||518||48|7|9|9|||9|12|||11|7|11|11|21||9|||11|10|||8|||||11|11||518|518|518|489|266|48|||34|286|12|12|7||7|7|33|23|32|85|32|46|35|11|11||||8|9||
new_0222_0463|ARQT|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0463|ARQT|201812|51.098|50.94||||75.085|2.673|72.412||-23.987|-24.276|||||||||||||||1.801||||||||18.0355||-0.3106|0.606|||35.0644|||-0.3106|||||||||-5.601|-5.601|||||||||||||||||||||||||5.347||||||||
new_0222_0463|ARQT|201903||||||||||||||||||||||||||||||||||18.0355||-0.3692|0.749||||||-0.3692|||||||||-6.658|-6.658|||||||||||||||||||||||||6.203|0.024|||||||
new_0222_0463|ARQT|201906||||||||||||||||||||||||||||||||||18.0355||-0.4597|1.324||||||-0.4597|||||||||-8.29|-8.29|||||||||||||||||||||||||7.214|0.001|||||||
new_0222_0463|ARQT|201909|27.771|25.177||0.485||81.253|8.599|72.654||-52.95|-53.704|||||||||||||||3.159||||||||18.0355||-0.8029|2.3|||35.0644|||-0.8029||||-35.029|||||-14.48|-14.48|||||||||||||||||||||||||12.348|0.019||||0.185|0.3||
new_0222_0463|ARQT|201912|106.474|101.265||0.491||172.041|5.237|166.804||-65.029|-66.272||||-16.1647|||||||||0.934|0.145|1.405||||||||35.0644|29|-0.3584|2.237|36.6269||35.0644|||-0.3584||||-41.996|||||-12.568|-12.568||21.8|21.8|697.2014|||355755|||||-9.21||33.4419||-6.13|||3.125|42.75|1.5|4|-26.665|-3.42|10.757|0.024|||||0.404|26.575|
new_0222_0463|ARQT|202003|253.878|249.319||0.467||12.51|12.222|0.288||241.882|-94.285||||-15.2367||||4.6166|||||3.1654||4.759|0.003|||||||24.2564|43|-1.15|3.469|37.472||37.472|||-1.15|-168.646|||-63.351|||||-28.013|-28.013||29.8|29.8|867.3466|228724.6||1186128|||||-0.8533||-34.7662||-1.15||||43.25|1.5|4|-3.3275|-3.2833|25.182|0.027||||0.241|0.226|29.72|33.55
new_0222_0463|ARQT|202006|228.035|223.975||3.857||23.047|19.281|3.766||208.923|-129.697||||-12.3058||||5.4554|||||4.4102||8.253|0.003|||||||37.5873|49|-0.94|5.618|37.6901||37.6901|||-0.94|0.004|||-90.473|||||-35.412|-35.412||30.24|30.24|915.7736|108256.3333||1662214|||||-0.8433||-11.4629||-0.94|||4.1667|43.25|1.5|4|-3.87|-4.1067|30.009|0.03||||0.228|3.629|26.7|25.07
new_0222_0463|ARQT|202009|194.121|189.712||3.814||24.942|21.154|3.788||173.071|-167.901||||-9.414||||6.3992|||||4.127|0.472|5.039|0.004|||||||37.7485|53|-1.01|5.56|37.7989||37.7989|||-1.01||||-114.197|||||-38.204|-38.204||29.3|29.3|917.7958|179545.0667||1559952|||||-0.8975||-12.5348||-1.01|||4.1667|44.5|1.5|4|-3.87|-4.1033|32.743|0.03||||0.322|3.492|17.82|27.12
new_0222_0463|ARQT|202012|292.826|284.441||5.365||27.648|22.602|5.046||270.621|-201.95||||-8.2456||||4.5049|||||3.8488|0.51|7.14|0.004||||0.2379|||43.0306|54|-0.74|6.69|43.3384||43.3384|||-0.74|-128.36|||-135.678|||||-34.049|-34.049||28.13|28.13|934.6682|232951.9333|19.7267|1668020||||235.5767|-0.86||8.1395||-0.79|||11.653|46.8|1.2|5|-3.842|-4.222|27.374|0.035|||||3.865|27.29|34.17
new_0222_0463|ARQT|202103|465.975|444.927||5.363||20.422|15.314|5.108||450.994|-237.992||||-7.1789||||3.2001|||||3.7266|0.577|3.146|0.005|||6|1.6709|||47.2808|75|-0.76|14.454|49.887||49.887|||-0.76|-207.49|||-143.707|||||-36.042|-36.042||28.93|28.93|998.3039|200596.8667|-2.9195|1859083||||278.8852|-0.97||21.6495||-0.76||||57.4|1.2|5|-4.688|-5.18|21.631|0.098||||3.269|0.702|33.5|26.35
new_0222_0463|ARQT|202106|427.554|409.364||5.26||18.404|13.347|5.057||414.488|-280||||-6.4119||||3.295|||||4.5173|0.399|2.676|0.005|||2|2.7437|||50.0007|108|-0.84|11.315|50.0456||50.0456|||-0.84||||-150.303|||||-42.008|-42.008||27.29|27.29|956.3804|205506.1667|-9.7553|2260701||||263.912|-0.9267||9.3528||-0.84|||8.653|56.7143|1.2857|7|-4.4114|-5.0729|30.765|0.104||||3.191|0.781|23.33|21.17
new_0222_0463|ARQT|202109|381.77|367.27||5.16||24.013|19.058|4.955||362.995|-336.98||||-5.3106||||3.2996|||||3.9438|0.362|4.871|0.005|||2|3.5193|||50.0979|143|-1.14|16.474|50.1348||50.1348|||-1.14||||-169.079|||||-56.98|-56.98||23.89|23.89|830.4504|164350.3333|-18.4642|1977196||||231.4436|-1.192||4.3624||-1.14|||9.7108|57.6667|1.2857|6|-4.2886|-4.9286|40.604|0.116||||3.115|0.873|21.18|16.57
new_0222_0463|ARQT|202112|||||||||||||||-4.322||||2.8737|||||4.2106||||||2|0.3525||||||||||||||||||||||||20.74|20.74|675.8545|233401.5333|-26.2709|2117724|||251.9624|13.7806|-1.542||||||5.48|4.14|55.1667|1.1667|6|-4.2417|-5.2983||||||||15.11|15.98
new_0222_0463|ARQT|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.39|||||||||||||||||||||
new_0222_0463|ARQT|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.33|||||||||||||||||||||
new_0222_0463|ARQT|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.31|1.9||||||||||||||||||||
new_0222_0463|ARQT|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.19|4.8||||||||||||||||||||